CORT Q4 2018 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+25.4% YoY

Gross Profit

$65M97.6% margin

Operating Income

$25M37.3% margin

Net Income

$22M32.9% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$21M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$312M

Total Liabilities

$36M

Stockholders' Equity

$276M

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$53M	+25.4%
Gross Profit	$65M	$52M	+25.2%
Operating Income	$25M	$22M	+14.8%
Net Income	$22M	$98M	-77.6%